- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate safety and tolerability of ODM-201 and to define dose(s) of ODM-201 for further clinical studies. Dose-limiting toxicities (DLT) and the MTD and/or OTD will be determined.
Inclusion criteria
- Progressive castration resistant prostate cancer (MedDRA: hormone-refractory prostate cancer)